81 related articles for article (PubMed ID: 23317234)
21. Expression of human Biot2 and its potential function on carcinogenesis in endometrial cancer.
Yangmei S; Xiang H; Hongxin D; Hanshuo Y; Feng P; Yuping X; Yuquan W; Xia Z
Acta Obstet Gynecol Scand; 2007; 86(12):1503-9. PubMed ID: 18027117
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
Goodfellow PJ; Buttin BM; Herzog TJ; Rader JS; Gibb RK; Swisher E; Look K; Walls KC; Fan MY; Mutch DG
Proc Natl Acad Sci U S A; 2003 May; 100(10):5908-13. PubMed ID: 12732731
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of the estrogen-receptor gene in endometrial carcinoma.
Kohler MF; Berkholz A; Risinger JI; Elbendary A; Boyd J; Berchuck A
Obstet Gynecol; 1995 Jul; 86(1):33-7. PubMed ID: 7784019
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
[TBL] [Abstract][Full Text] [Related]
25. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
[TBL] [Abstract][Full Text] [Related]
26. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro.
Zaug AJ; Podell ER; Cech TR
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10864-9. PubMed ID: 16043710
[TBL] [Abstract][Full Text] [Related]
27. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.
Sun L; Sui L; Cong X; Ma K; Ma X; Huang Y; Fan C; Fu X; Ma K
Cancer Genet; 2014; 207(7-8):291-8. PubMed ID: 25242236
[TBL] [Abstract][Full Text] [Related]
28. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
29. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
Saegusa M; Hashimura M; Yoshida T; Okayasu I
Br J Cancer; 2001 Jan; 84(2):209-17. PubMed ID: 11161379
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
Xu JY; Zhu WJ; Cao XZ; Li XF; Wu J
Int J Gynecol Cancer; 2011 Apr; 21(3):430-4. PubMed ID: 21436690
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of mRNA expression of estrogen receptor beta and its isoforms in human normal and neoplastic endometrium.
Skrzypczak M; Bieche I; Szymczak S; Tozlu S; Lewandowski S; Girault I; Radwanska K; Szczylik C; Jakowicki JA; Lidereau R; Kaczmarek L
Int J Cancer; 2004 Jul; 110(6):783-7. PubMed ID: 15170658
[TBL] [Abstract][Full Text] [Related]
33. Identification of exon-deleted progesterone receptor mRNAs in human uterine endometrial cancers.
Misao R; Nakanishi Y; Sun W; Iwagaki S; Fujimoto J; Tamaya T
Oncology; 2000; 58(1):60-5. PubMed ID: 10644942
[TBL] [Abstract][Full Text] [Related]
34. [Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor messenger RNA in human endometrium and endometrial carcinoma].
Sato A; Bo M; Otani T; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1995 May; 47(5):473-8. PubMed ID: 7775814
[TBL] [Abstract][Full Text] [Related]
35. Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis.
Seki N; Kodama J; Hashimoto I; Hongo A; Yoshinouchi M; Kudo T
Int J Oncol; 2001 Aug; 19(2):305-10. PubMed ID: 11445843
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
[TBL] [Abstract][Full Text] [Related]
37. MMAC/PTEN gene expression in endometrial cancer: RT-PCR studies.
Sobczuk A; Smolarz B; Romanowicz-Makowska H; Pertyński T
Pol J Pathol; 2006; 57(3):137-40. PubMed ID: 17219740
[TBL] [Abstract][Full Text] [Related]
38. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer.
Fishman A; Klein A; Zemer R; Zimlichman S; Bernheim J; Cohen I; Altaras MM
Gynecol Oncol; 2000 Jun; 77(3):399-404. PubMed ID: 10831349
[TBL] [Abstract][Full Text] [Related]
39. MSH2 splice site mutation and endometrial cancer.
Bianchi F; Rosati S; Belvederesi L; Loretelli C; Catalani R; Mandolesi A; Bracci R; Bearzi I; Porfiri E; Cellerino R
Int J Gynecol Cancer; 2006; 16(3):1419-23. PubMed ID: 16803540
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
Kohler MF; Marks JR; Wiseman RW; Jacobs IJ; Davidoff AM; Clarke-Pearson DL; Soper JT; Bast RC; Berchuck A
J Natl Cancer Inst; 1993 Sep; 85(18):1513-9. PubMed ID: 8360934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
